T. Rowe Price Investment Management’s AbbVie ABBV Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $217M | Buy |
1,171,606
+12,357
| +1% | +$2.29M | 0.14% | 169 |
|
|
2025
Q1 | $243M | Buy |
1,159,249
+1,153,249
| +19,221% | +$242M | 0.16% | 147 |
|
|
2024
Q4 | $1.07M | Sell |
6,000
-4,661,205
| -100% | -$829M | ﹤0.01% | 601 |
|
|
2024
Q3 | $922M | Sell |
4,667,205
-158,508
| -3% | -$31.3M | 0.56% | 50 |
|
|
2024
Q2 | $828M | Sell |
4,825,713
-11,169
| -0.2% | -$1.92M | 0.52% | 58 |
|
|
2024
Q1 | $881M | Sell |
4,836,882
-5,246
| -0.1% | -$955K | 0.54% | 56 |
|
|
2023
Q4 | $750M | Sell |
4,842,128
-1,409,077
| -23% | -$218M | 0.49% | 59 |
|
|
2023
Q3 | $932M | Buy |
6,251,205
+253,644
| +4% | +$37.8M | 0.66% | 37 |
|
|
2023
Q2 | $808M | Sell |
5,997,561
-1,599,942
| -21% | -$216M | 0.55% | 47 |
|
|
2023
Q1 | $1.21B | Buy |
7,597,503
+4,317,571
| +132% | +$688M | 0.87% | 29 |
|
|
2022
Q4 | $530M | Buy |
+3,279,932
| New | +$530M | 0.41% | 74 |
|